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itochondria are remarkable microorganisms. 
About two billion years ago, their distant free-living 
ancestors hooked up with a truly foreign lineage 
of archaebacteria and started a genomic merger that led to 
the most successful coevolved mutualism on the planet: the 
eukaryotic cell. Along the way, evolving mitochondria lost 
a lot of genomic baggage, entrusted their emerging hosts 
with their own replication, sorted out genomic conflicts by 
following maternal inheritance, and have mostly abstained 
from sex and recombination. What mitochondria did retain 
was a subset of genes that encode critical components of the 
electron transport chain and ATP synthesis enzymes that 
carry out oxidative phosphorylation. Because mitochondria 
house the biochemical machinery that requires us to breathe 
oxygen, it was first assumed that mitochondrial genes would 
show very slow rates of molecular evolution. So it was big 
news almost 30 years ago when mitochondrial DNA (mtDNA) 
evolution was observed to be quite rapid [1]. How could the 
genes for a highly conserved and critical function sustain the 
consequences of high mutation pressure and permit rapid 
rates of nucleotide substitution between species? Without the 
benefits of recombination, where offspring can carry fewer 
mutations than either parent, mutations should accumulate 
in mitochondrial genomes through the random loss of 
less-mutated genomes, a process referred to as Muller’s 
ratchet [2,3]. How have mitochondria avoided a mutational 
meltdown, or at least significant declines in fitness?
In many ways, these questions were set aside by researchers 
to capitalize on the tremendous opportunity that a rapidly 
evolving, nonrecombining, maternally inherited, easily 
sequenced set of homologous genes could provide: a window 
into the evolutionary history of populations and closely 
related species [4]. Indeed, mtDNA is still the first marker 
of choice for evolutionary analysis. It has played a major role 
in uncovering the evolutionary histories of a wide diversity 
of organisms, most notably our own origin and evolution 
from African roots [5,6]. The high rate of mtDNA evolution 
may have led to the assumption that most mtDNA mutations 
are essentially neutral and not subject to the effects of 
natural selection. But in recent years, there has been great 
interest in returning to the question of how mitochondria 
sustain themselves in the face of high mutation pressure 
and critically examining the evidence for the variety of ways 
that natural selection can shape the evolution of mtDNA 
[7–9]. It is now clear that mitochondrial mutations are a 
significant factor in many mitochondrial diseases [10,11]. 
Population and evolutionary analyses have shown that much 
of mtDNA variation is not consistent with the neutral model 
of evolution, and there is a growing debate over the relative 
roles of random genetic drift versus positive Darwinian and 
negative purifying selection in shaping mtDNA evolution 
[12,13].
Mutation, Polymorphism, and Substitution Are Not 
the Same Thing
Rapid rates of sequence evolution can be attributed to two 
things: high mutation rate or low functional constraint. 
Inferring the actual mutation rate from patterns of sequence 
divergence between species, or even from variation within 
species, can be a problem because it makes clear assumptions 
about the neutrality of mutations. When mutations are strictly 
neutral, they have no detrimental or beneficial effects on 
the survivorship or reproduction of the organism, and their 
establishment in a population is a matter of chance (see 
Figure 1). Since most mutations are detrimental and are 
removed by selection, more mutations will be produced than 
are ever observed as polymorphisms within a population. 
Mutations that enter the population through individuals 
fit enough to reproduce must persist for many generations 
before they become fixed in the population. 
In populations of finite size, weakly deleterious alleles can 
persist and even become fixed due to the random sampling 
of genetic drift. Likewise, more mutations will be observed 
as polymorphisms within populations than are observed as 
fixed substitutions between species. If mutations are generally 
deleterious, mutations will outnumber polymorphisms, 
which will outnumber fixation (substitution) events. If 
mutations are generally beneficial, levels of polymorphism 
or divergence can be higher than for deleterious mutations, 
but by an amount that depends on many population 
genetic factors (strength of selection, population size, local 
recombination rate, etc). Thus, one can only estimate 
the mutation rate from levels of polymorphism within, or 
substitution between, species for strictly neutral mutations. 
But how do we find out which mutations are neutral? And 
how do we estimate evolutionary time if mutation rates 
differ from substitution rates? At stake is the accuracy 
of evolutionary inference in a wide array of problems in 
evolutionary genetics [9,14].
There are two simple solutions to this problem: use DNA 
neutrality tests that compare patterns of polymorphism 
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and fixation for nucleotide sites with different functional 
constraints (e.g., the McDonald-Kreitman or MK test of 
nonsynonymous versus synonymous mutations in protein 
coding regions [15]), or measure mutations in pedigrees or 
sets of mutation accumulation lines where selection has been 
weak or absent (see Figure 1). In the case of mtDNA, both of 
these approaches have provided evidence for selection against 
mildly deleterious mutations. In mitochondrial protein 
coding genes, the ratio of nonsynonymous/synonymous (dN/
dS) polymorphisms within species is greater than this ratio 
between species (see Figure 1B), consistent with a purging of 
weakly selected amino acid–altering polymorphisms [16,17]. 
In pedigree studies, the mutation rate can be estimated by 
the frequency of new mtDNA variants observed in a sample 
of descendants from a founding mother. These analyses 
typically show that the “pedigree rate” of mutation exceeds 
the estimated “phylogenetic rate” of mutation by as much 
as a factor of 10 [18,19]. Since the “phylogenetic rates” 
are estimated by comparing substitutions between species 
on a phylogeny (or evolutionary lineage), they measure 
substitution, not mutation rate. Together, these data 
imply that mutations introduced into a pedigree are being 
eliminated before they become fixed within that species. 
Some studies have combined these approaches by 
sequencing mitochondrial genomes from a set of mutation 
accumulation (MA) lines [20], or in lineages with very 
different population sizes [21]. In Caenorhabditis elegans, the 
dN/dS ratio among MA lines exceeds that observed among 
wild strains, consistent with a relaxation of purifying selection 
among the MA lines [20]. In the water flea, Daphnia, sexual 
species have larger effective population sizes than asexual 
lineages, resulting in weaker selection in asexual lineages. As 
predicted by a model of purifying selection on mtDNA, the 
asexual lineages show significantly larger dN/dS ratios than 
the sexual lineages, and analyses confirm that this is due to 
elevated rates of nonsynonymous evolution in the asexual 
lineages [21,22]. A similar effect is seen in comparisons of 
mtDNA divergence in large versus small mammal species, 
where large body size is associated with smaller population 
size, weaker purifying selection, and hence more rapid 
accumulation of deleterious mutations [23].
Again, all of these studies document that mutation does 
not equal polymorphism, and polymorphism does not equal 
fixation, consistent with the pervasive effects of purifying 
selection against deleterious nonsynonymous mutations. 
If the purging of deleterious mutations is as pervasive as it 
appears, these data address the question of how mitochondria 
can persist in the face of high mutation pressure.
Bottlenecks and the Units of Selection Can Slow the 
Advance of Muller’s Ratchet
But what has been lacking from these studies is a 
comprehensive look at the very early stages of this mutation 
process. When an mtDNA mutation occurs, it generates 
doi:10.1371/journal.pbio.0060035.g001
Figure 1. Patterns of Polymorphism for Mutations of Different Effects
(A) A graph illustrating general trajectories of neutral, advantageous, deleterious, and balanced mutations. Below is a table listing the likelihood 
of observing these mutations as polymorphisms in a sample from within a population, or as fixed differences between species. Note that neutral, 
advantageous, and deleterious mutations make clearly distinct predictions. 
(B) An example of a McDonald-Kreitman test using the counts of nonsynonymous (N) and synonymous (S) mutations within and between species, or 
lineages of a pedigree. In the data shown, the dN/dS ratio is higher within species than between species, a pattern seen in many mtDNA data sets, and 
in the mutator mouse pedigree study reported by Stewart et al. PLoS Biology  |  www.plosbiology.org PLoS Biology  |  www.plosbiology.org 0231 February 2008  |  Volume 6  |  Issue 2  |  e35
heteroplasmy, or a mixed population of mtDNAs within the 
cell. Because new mutations are nested in a hierarchy of 
populations (multiple mtDNAs within each mitochondria, 
multiple mitochondria per cell, many oocytes per female 
that may give rise to an offspring, and variable numbers 
of breeding females in natural populations), mutation 
and selection are closely connected. At any stage in 
the transmission though this hierarchy of populations, 
bottlenecks or genetic drift due to sampling of mtDNAs 
generate variation among lower units within higher units 
(e.g., mitochondria within cells, or oocytes within individual 
germ lines), which provides raw material for natural 
selection to act upon. As mutations accumulate in germline 
mitochondria, this variation can more effectively purge 
deleterious mutations than under conditions of purely clonal 
transmission of nonrecombining mtDNA [24]. This will delay 
the “ratchet” effects of mutational decline envisioned by 
Muller [25,26]. To get an accurate picture of how selection 
purges new mitochondrial mutations, we would like to 
document patterns of mutation, polymorphism, and fixation 
among units in this hierarchy.
In a recent issue of PLoS Biology, a new study [27] by James 
Stewart et al. provides a thorough analysis of how natural 
selection removes mutations from maternal lineages of 
mice and describes patterns of variation that are remarkably 
similar to those found in human populations. The data 
provide a very clear picture of purifying selection in action. 
The researchers took advantage of a knock-in mouse model 
that carries a mutation for the proofreading activity of 
the mitochondrial DNA polymerase, polymerase gamma 
(polgAmut/polgAmut) [28,29]. These mice have elevated mtDNA 
mutation rates, accelerated senescence, and a number of 
phenotypes associated with mitochondrial diseases. Mice 
homozygous for this mutation were bred to a standard lab 
strain to generate homozygous wild-type F2 offspring with 
normal mtDNA polymerase function (polgA+/polgA+). Because 
these F2 mice descended from the homozygous mutant 
mother, they carried a mixed population of mutant mtDNAs 
in their germ line and somatic tissues. 
Stewart et al. sequenced the complete mtDNAs from 190 
mice in the pedigree, from F2–F6. Many more mutations were 
observed in the third codon positions of the protein coding 
genes, consistent with selection against amino acid–altering 
mutations that are more common in first and second codon 
positions. Earlier work on a small sample of homozygous 
mutant mice showed that initial mutations were equally 
likely to occur at all codon positions [28,29], which should 
generate a dN/dS value of approximately 1.0. The overall 
dN/dS ratio was 0.6035, and this value dropped to 0.4617 
when mutations observed in single mice were excluded. Thus, 
rare mutations were more likely to be nonsynonymous and 
were purged, as expected under purifying selection. The dN/
dS ratio was significantly higher among the mutator strain 
pedigree mice than that for polymorphism among 21 wild-
type strains of mice, or for divergence to a different species, 
Mus musculus molossinus. Stewart et al. further show that the 
observed mutations at 4-fold degenerate codon positions 
(those that can mutate to any nucleotide without altering the 
encoded amino acid and hence are very close to neutral) are 
significantly more homogeneous across mitochondrial genes 
than non-4-fold degenerate sites, suggesting more selection 
on functionally constrained nucleotide changes. This rate 
differential was most pronounced for the cytochrome 
oxidase subunits, which are the most evolutionary conserved 
mitochondrial proteins.
The observed patterns of nonsynonymous and synonymous 
changes across the first, second, and third codon positions 
of protein coding genes in the mutator mouse data were 
evident by the F2 generation, suggesting that selection to 
remove amino acid changes occurs very rapidly in mouse 
pedigrees. Notably, these patterns of variation across codon 
positions were remarkably similar to those for a sample of 
complete human mtDNAs, implying that most of the purging 
of deleterious mutations in mammals occurs in the few 
generations after the mutations are introduced. 
For transfer RNA, ribosomal RNA genes, and the 
noncoding D-loop, the patterns of mutation observed in the 
mutator mouse data were curiously different than those for 
wild-type mouse strains or humans. In most animals, variation 
in mitochondrial tRNAs and rRNAs is typically much lower 
than that observed in D-loop regions, but the mutator mice 
showed high mutation rates in tRNAs. Interestingly, tRNAs 
comprise less than 10% of the mtDNA coding DNA, but 
account for almost 60% of human pathogenic mutations. This 
has been taken as evidence for an important role of tRNA 
mutations in mitochondrial disease. But pathogenic tRNA 
mutations often must reach high heteroplasmic frequencies 
within the cell before they have pathogenic effects [11]. The 
new mutator mouse data suggest that negative selection on 
tRNAs may be rather mild. This observation warrants further 
study, given the common association of mt-tRNA mutations in 
disease.
What Is To Be Done?
What do these results tell us about how mtDNA mutation 
and selection govern mitochondrial function? And how 
might this affect evolutionary inference using mtDNA? 
The strong signature of negative selection on the protein 
coding sequences in mtDNA, and rather limited evidence 
for selection on the RNA genes, suggest that the purging 
of deleterious mtDNA acts via selection on physiological 
and biochemical performance of individual mitochondria, 
oocytes, and possibly individual mice in these pedigrees. 
As any good result should do, this study raises more 
questions than it answers. How are the individual mutations 
partitioned within and among mitochondria within oocytes? 
Do mitochondria with more mutated mtDNAs replicate 
at a slower rate due to reduced oxidative phosphorylation 
activity? Do oocytes with more mutant mtDNAs fail in early 
embryogenesis at a higher rate than oocytes carrying a lower 
load of mutations? Is selection on mice in the pedigrees due 
to early selection on embryos, or to tissue-specific failures 
later in development? 
Answers to these questions will require detailed sampling 
from oocytes, embryos, and neonates in larger pedigrees, but 
such data are as relevant to evolutionary genetics as they are 
to medical questions related to fertility [8,30]. It is easy to 
imagine how the distribution of mtDNA mutations among 
oocytes and embryos could provide the raw material for 
strong purifying selection.
If the selection against deleterious mutations is largely 
complete within a few generations, then what can we 
infer about the consistent pattern of excess amino acid 
polymorphism in natural populations, including humans? PLoS Biology  |  www.plosbiology.org PLoS Biology  |  www.plosbiology.org 0232 February 2008  |  Volume 6  |  Issue 2  |  e35
This pattern would suggest that most of the amino acid 
variants found within populations are indeed mildly 
deleterious, with an emphasis on mild. Nevertheless, 
mitochondrial mutations are a very common form of 
metabolic disease, so deleterious mutations are continuing 
to enter the human population. If excess polymorphism is 
a common pattern, then molecular clock approaches that 
infer age of the most recent common ancestor in humans 
will be overestimates. Methods to correct for apparent rate 
differences between short-time-frame and long-time-frame 
estimates of the most recent common ancestor have been 
developed [14], and certainly should be more widely applied 
for mtDNA [9]. 
The new mouse study also begs new questions about 
positive selection on mtDNA. The mutator mouse model 
[27] should certainly have generated some point mutations 
that are beneficial, so it is interesting that no signature of a 
selective sweep leading to fixation of a novel mtDNA variant 
was evident in the data. For such an event to have occurred, 
the presumed positively selected site(s) would have to have 
a net selection coefficient great enough to overcome the 
negative selection acting on mutations on the same mtDNA 
molecule, as well as on others in the hierarchy of populations 
within that pedigree. Methods are now available to estimate 
the distribution of fitness effects of mutations when a general 
pattern of negative selection is apparent that may include 
a mixture of advantageous and deleterious mutations [31]. 
Additional studies of this type are needed to provide context 
for recent reports of positive selection on mitochondrial 
genes [12,32–34]. ◼
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